ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08485
0,00%
Bitcoin
69.210,95
-0,08%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Humacyte Inc (HUMA)

  7. Humacyte Inc (HUMA) News

HUMA

Humacyte (HUMA)

Humacyte Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HUMA
DatumZeitQuelleÜberschriftSymbolFirma
08/03/202422h03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HUMAHumacyte Inc
04/03/202412h53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
29/02/202422h11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:HUMAHumacyte Inc
29/02/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
09/02/202414h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
12/12/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202322h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202322h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202322h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202322h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/12/202314h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
09/11/202322h28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HUMAHumacyte Inc
09/11/202322h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
10/10/202322h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
10/10/202322h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
15/09/202322h09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HUMAHumacyte Inc
15/09/202322h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
15/09/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
12/09/202313h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
12/09/202302h03Dow Jones NewsStocks to Watch: Oracle, Acelyrin, HumacyteNASDAQ:HUMAHumacyte Inc
22/08/202300h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
22/08/202300h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
22/08/202300h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
17/08/202322h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAHumacyte Inc
14/08/202314h44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HUMAHumacyte Inc
14/08/202313h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
31/07/202319h28Dow Jones NewsHumacyte Shares Rise 8% After Completing Enrollment in Phase 2/3 TrialNASDAQ:HUMAHumacyte Inc
26/07/202314h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
 Showing the most relevant articles for your search:NASDAQ:HUMA

Kürzlich von Ihnen besucht

EU
STSL
Leverage
SUSHI
TUSDUSDT
TrueUSD
TSX
ZUCM.U
BMO USD Cash Management ...
COIN
BARTUSD
BarterTrade
CRTO
AVAXBTC
Avalanche
BIT
GS0244
Goldman Sachs Finance
NYSE
MBE
NASDAQ
TOP
TOP Financial
UNSW
EPAYETH
EthereumPay
ASX
NIM
Nimy Resources
ASX
COJ
Commstrat
AMEX
EWGS
iShares MSCI Germany Sma...
COIN
GREEDCUSD
NASDAQ
SELB
Selecta Biosciences
BIT
SNSR
Global X Internet Of Thi...
LSE
0IVY
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten